Abstract
Background Healthy Minds Thriving Kids (HMTK) is a free to user mental health prevention program developed by the Child Mind Institute with the aim to normalize conversations about mental health and provide educators with wellness tools.
Methods The HMTK program was available to view by registrants between 26th January 2022 and 7th September 2022 in the State of California. Participants viewed an introductory video for the program and a minimum of two skills videos before participating in an online survey.
Results Of 68,861 registrants to the website 64,376 provided survey data. Post-pandemic levels of stress and anxiety were increased and 89.5% of respondents said young people required a greater degree of support than previously. Almost all educators (90%) want additional mental health and wellbeing tools for students and following review of HMTK >80% of respondents said they would use the program in their classrooms. Most (86.6%) found the program engaging and 85.1% found the program relevant to, and representative of, their student cohorts. More than three quarters (79.6%) said their students would find the program engaging and beneficial, and 18.8% more educators believed that HMTK was indicative of commitment to educators by the State of California in supporting students’ social and emotional learning.
Conclusion This survey demonstrates that the HMTK program is a valuable and complementary resource to school curricula to improve the mental health and wellbeing of young people. It provides an easy to implement framework that school districts and administrators can allocate within their curriculum planning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB exemption provided by ADVARRA IRB ADVARRA IRB is registered with OHRP and FDA under IRB#00000971 Exemption #: Pro00079335 Date of exemption: 15th May 2024 IRB exemption was provided as study meets the criteria of 45 CFR 46.104(d) 4 The IRB exemption has been provided as part of the cover letter
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are provided in the supporting information
